Renue By Science — Liposomal NMN
Liposomal-encapsulated NMN at 250mg — the bioavailability-focused NMN that goes head-to-head with Tru Niagen on the precursor question.
Liposomal-encapsulated NMN from one of the longer-running brands in the NAD+ precursor space — built on the bet that delivery vehicle matters as much as the molecule.
Renue By Science has been selling NMN since 2018 — one of the longer-tenured brands in a category most buyers think started with David Sinclair's 2019 podcast tour. The Liposomal NMN product is their flagship: 250mg of NMN encapsulated in phosphatidylcholine liposomes.
The liposomal pitch: NMN is a relatively unstable molecule that may degrade in the digestive tract. Liposomal encapsulation is designed to track higher absorption rates by protecting the active compound through stomach acid. Renue uses this approach across most of their NAD+ precursor lineup (also liposomal, sublingual, powder NMN forms).
Where it wins: deep product line for buyers who want to compare delivery formats. Renue sells liposomal, sublingual, and powder NMN — meaning a buyer can experiment with which form they observe and feel works best. Refersion affiliate program offers 60-day cookie window — among the longest in the supplement category.
Compliance posture matters here. NMN as a category has faced FDA scrutiny since 2022 when the agency issued letters classifying NMN as a drug investigation compound. Several NMN brands, including Renue at various points, have been subject of BBB / NAD inquiries about claims-language. Editorial coverage on Lifespan Vault tracks product, brand history, and observed user experience — never therapeutic or outcome claims — and notes that NMN regulatory status is in flux. Tru Niagen / NR has cleaner regulatory standing for buyers concerned about long-term supplement availability.
The bioavailability question is more contested than the marketing implies. Liposomal delivery for NMN specifically has fewer published comparison studies than the technology has for vitamin C or glutathione. Buyers should treat the liposomal pitch as a credible-but-unproven optimization, not a settled advantage.
Existing NMN protocol users who want to experiment with liposomal delivery, and longevity-pro buyers who prefer NMN over NR and value Renue's 60-day cookie and brand longevity.
You want the most evidence-backed NAD+ precursor (Tru Niagen / NR has more published trials), you're concerned about NMN regulatory uncertainty, or you're a first-time NAD+ precursor buyer.
Pros
- Liposomal delivery vehicle — designed to track higher absorption than free-form NMN
- 250mg dose at 2 capsules — flexible dosing for protocol customization
- Renue brand in NMN category since 2018 — among the longest-tenured
- Deep product line (liposomal, sublingual, powder NMN)
- Refersion affiliate program with 60-day cookie — among longest in category
- ~15% affiliate commission rate
- Strong content arm and podcast supporting the NAD+ research community
- Subscribe & save ~10-15% off list
- Manufactured in cGMP facilities with third-party testing
- Direct response community / repeat-buyer base
Cons
- NMN as a category faces ongoing FDA scrutiny — regulatory status less clear than NR
- BBB / NAD compliance precedent in the broader NMN category requires careful claims language
- Liposomal bioavailability advantage extrapolated from general research, not NMN-specific RCTs
- $80-120/mo cost is at the high end of NAD+ precursor pricing
- Less institutional credibility than ChromaDex / Tru Niagen
- Long-term product availability less certain if FDA tightens NMN classification
Specifications
Most often compared with
Renue By Science — Liposomal NMN
$80–$120/mo · Verified 2026-05-03
View at Renue By Science →